[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2013002841A - Immunogenic compositions. - Google Patents

Immunogenic compositions.

Info

Publication number
MX2013002841A
MX2013002841A MX2013002841A MX2013002841A MX2013002841A MX 2013002841 A MX2013002841 A MX 2013002841A MX 2013002841 A MX2013002841 A MX 2013002841A MX 2013002841 A MX2013002841 A MX 2013002841A MX 2013002841 A MX2013002841 A MX 2013002841A
Authority
MX
Mexico
Prior art keywords
conjugate
conjugated
gbs
capsular saccharide
carrier protein
Prior art date
Application number
MX2013002841A
Other languages
Spanish (es)
Other versions
MX349930B (en
Inventor
Mario Contorni
Paolo Constantino
Francesco Berti
Oretta Finco
John Telford
Guido Grandi
Domenico Maione
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101665.6A external-priority patent/GB201101665D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2013002841A publication Critical patent/MX2013002841A/en
Publication of MX349930B publication Critical patent/MX349930B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides an immunogenic composition comprising: a) a conjugate that is a capsular saccharide from GBS serotype la conjugated to a carrier protein; b) a conjugate that is a capsular saccharide from GBS serotype lb conjugated to a carrier protein; and c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein. The invention also provides a method for immunising a patient against infection by GBS comprising the step of administering to the patient a conjugate that is a capsular saccharide from GBS conjugated to a diphtheria toxoid or derivative thereof, wherein the patient has been pre-immunised with a diphtheria toxoid or derivative thereof.
MX2013002841A 2010-09-16 2011-09-16 Immunogenic compositions. MX349930B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38366810P 2010-09-16 2010-09-16
GBGB1101665.6A GB201101665D0 (en) 2011-01-31 2011-01-31 Immunogenic compositions
PCT/IB2011/054069 WO2012035519A1 (en) 2010-09-16 2011-09-16 Immunogenic compositions

Publications (2)

Publication Number Publication Date
MX2013002841A true MX2013002841A (en) 2013-05-30
MX349930B MX349930B (en) 2017-08-21

Family

ID=55435157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002841A MX349930B (en) 2010-09-16 2011-09-16 Immunogenic compositions.

Country Status (3)

Country Link
JP (1) JP2016029103A (en)
MX (1) MX349930B (en)
ZA (1) ZA201301908B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2017170494A1 (en) * 2016-03-29 2019-02-14 国立大学法人 東京大学 Anti-obesity vaccine

Also Published As

Publication number Publication date
ZA201301908B (en) 2019-08-28
MX349930B (en) 2017-08-21
JP2016029103A (en) 2016-03-03

Similar Documents

Publication Publication Date Title
GB201101665D0 (en) Immunogenic compositions
MX2024006606A (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof.
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
MY167579A (en) Glycoconjugation processes and compositions
EA201391788A1 (en) VACCINE CONTAINING CONJUGATES OF CAPSULAR POLYSACCHARIDES STREPTOCOCCUS PNEUMONIAE
WO2020131763A3 (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2007113223A3 (en) Immunogenic composition
NO20082646L (en) Vaccine
IN2012DN02736A (en)
WO2011027222A3 (en) Immunogenic compositions including tlr activity modulators
MX2015002483A (en) Immunogenic compositions.
IN2014DN09791A (en)
EA033488B1 (en) Method of immunising against staphylococcus aureus infection
WO2012106251A3 (en) Pertussis vaccine
MX2017016858A (en) Immunogenic compositions.
EA201290319A1 (en) APPLICATION OF L3 AND / OR L5 SOURCE AS A VACCINE OR DIAGNOSTIC MEANS FOR PARASITIC DISEASE
MX336359B (en) Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound.
MX2015013401A (en) Method of treatment.
MX349930B (en) Immunogenic compositions.
WO2009129498A3 (en) Substance p and analogs thereof as a cancer immunogenic composition adjuvant
JO3420B1 (en) Pharmaceutical composition and vaccine against staphylococcal infections
UA58747U (en) method for medical rehabilitation of patients with non-alcohol steatohepatitis

Legal Events

Date Code Title Description
GB Transfer or assignment

Owner name: GLAXOSMITHKLINE BIOLOGICALS SA

FG Grant or registration